Robinhood Launches AI Agents That Trade and Spend for Users Milwaukee Brewers Top Prospect Jesus Made Could Bolster Franchise Value and Competitive Position PutinXi Talks Signal Potential Revival of Power of Siberia 2 Pipeline Amid Iran ConflictDriven Energy Volatility Quartz Report Highlights 7 Strategies to Reduce Spending on Groceries Bills and Shopping AIInfrastructure and Energy Basket Outperforms Nvidia Doubling Investor Returns Love Factually Dating Startups Deploy Novel Approaches to Combat Fake Profiles EverQuote Q1 2026 Earnings EPS Surpasses Expectations by 1402 Stock Declines Amid Unclear Revenue Outlook HA Sustainable Infrastructure Capital Inc HASI Q1 2026 Earnings Strong EPS Beat Mitigates Revenue Uncertainty Stock Holds Steady JXN Q1 2026 Earnings EPS Misses Estimates Amid Market Uncertainty Ocular Therapeutix Q1 2026 Earnings EPS Misses Estimates as RD Investments Continue PRAX Q1 2026 Earnings EPS Beat Amid Continued RD Focus Champions Oncology Inc CSBR Q1 2026 Earnings Earnings Miss Estimates as EPS Falls to 002 Farmers Merchants Bancorp FMAO Slips 1 Support and Resistance Levels in Focus Space Asset Acquisition Corp Units SAAQU Hold Steady at 106 Amid Minimal Price Movement Cohen Steers Real Estate Opportunities and Income Fund RLTY Edges Higher Amid Modest Gains Ocean Power Technologies Inc OPTT Surges Over 6 as Stock Tests Key Resistance Level IAE Inches Higher Modest Gains Amid Asia Pacific Dividend Focus ASIX Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions FBRX Q1 2026 Earnings PreRevenue Biotech Reports Narrow EPS Miss Amid Ongoing Development Saratoga Investment Corp 8125 Notes due 2027 SAY Q1 2026 Earnings Steep EPS Miss Weighs on Sentiment Despite Modest Price Recovery ZBIO Q1 2026 Earnings Loss Narrows as EPS Surprises to the Upside BSET Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Furniture Market Cautiously Optimistic on India Geosphere Capital Eyes Earnings Revival Union Pacific Corporation UNP Q1 2026 Earnings EPS Beat Amid Operational Efficiency Gains Treace Medical Concepts TMCI Advances 397 as Stock Tests Key Resistance at 317